Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

Antibiotic resistance is a globally growing health threat, which is projected to take more lives than all forms of cancer combined by 2050 if it cannot be controlled. (1) Nowadays, there is a general ...